Jeffrey E. Lancet, MD - Maximizing Outcomes With Allogeneic HCT in AML: Insight on the Impact of Novel Therapy

Maximizing Outcomes With Allogeneic HCT in AML: Insight on the Impact of Novel Therapy

Source: PeerView CME/CE Audio Podcast - Oncology - April 19, 2017 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts